CLINICAL_TRIALS
trial_result
· 2014-02-12
Clinical Trial Update: Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism- [Phase 4]
Summary
Phase 4 clinical trial evaluating the effects of aripiprazole on glucose metabolism in patients with schizophrenia; results have been posted for this completed …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-02-12